CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 1,816	$ 1,275
Other current assets	68	98
Total current assets	1,884	1,373
Patent license rights, net	78	196
Total assets	1,962	1,569
Current liabilities
Accounts payable	415	197
Other accrued liabilities	2	2
Total current liabilities	417	199
Secured debt and accrued interest, net of unamortized issuance costs	2,415	2,249
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 150,000,000 shares authorized; 54,385,411 shares outstanding in 2018 and 2017	27	27
Additional paid-in capital	190,479	190,468
Accumulated deficit	(191,376)	(191,374)
Total Capstone Therapeutics Corp. stockholders' equity (deficit)	(870)	(879)
Noncontrolling interest	0	0
Total equity	(870)	(879)
Total liabilities and equity	$ 1,962	$ 1,569

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).